secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tango Therapeutics, Inc. (TNGX)
CIK:        0001819133
Form:       8-K
Filed at:   2026-06-04T21:19:05+00:00
Accession:  0001193125-26-257760
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tango Therapeutics annual meeting elects two Class II directors, ratifies auditor, approves NEO compensation
--------------------------------------------------------------------------------

- Peters elected with 98,188,796 for; 17,623,596 withheld; Rothenberg with 92,476,172 for; 23,336,220 withheld.
- Ratification of PricewaterhouseCoopers as 2026 auditor: 131,097,992 for, 73,823 against, 26,266 abstain.
- Advisory vote on named executive officer compensation: 113,915,877 for, 1,855,838 against, 40,677 abstain.
- Director Kanishka Pothula resigned effective May 13, 2026 prior to meeting; not a disagreement with company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819133/000119312526257760/0001193125-26-257760-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819133/000119312526257760/d149262d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-257760

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer